Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemangiosarcoma × Interviews as Topic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 40 Breast Neoplasms 30 Prostatic Neoplasms 26 Colorectal Neoplasms 24 Lung Neoplasms 15 Ovarian Neoplasms 10 Hematologic Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 8 Lymphoma 7 Uterine Cervical Neoplasms 6 Multiple Myeloma 6 Leukemia 6 Depression 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Endometrial Neoplasms 5 Urinary Bladder Neoplasms 4 Rectal Neoplasms 4 Mouth Neoplasms 4 Motor Activity 4 Head and Neck Neoplasms 4 Gastrointestinal Neoplasms 4 Anxiety Disorders 4 Advanced Cancer 4 Pancreatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematopoietic and Lymphoid System Neoplasm 3 Disease 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Brain Neoplasms 3

Interventions

Paclitaxel 6 Doxorubicin 5 pembrolizumab 4 pazopanib 4 Gemcitabine 4 durvalumab 3 Radiotherapy 3 Propranolol 3 Docetaxel 3 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Nivolumab 2 Ifosfamide 2 Bevacizumab 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 tremelimumab 1 trebananib 1 trastuzumab duocarmazine 1 talazoparib 1 spartalizumab 1 sintilimab 1 selinexor 1 sarilumab 1 ribociclib 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡